Literature DB >> 1854689

Iris clipping of a diode laser beam when performing retinal photocoagulation.

W H Woon1, T J ffytche, A M Hamilton, J Marshall.   

Abstract

The Microlase infrared diode laser has recently become available for retinal photocoagulation. It uses a laser beam with a large convergence angle (23 degrees). This gives rise to a laser beam with a relatively large cross section at the subject's pupil. In this study the pupillary area required to view the fundus at the slit-lamp with a 90-dioptre lens is determined. It is found that the pupillary area required to view the fundus is smaller than the cross section of the Microlase laser beam at the pupil. Thus iris clipping of the laser beam can occur even though the surgeon has a clear and bright view of the fundus. Care should be taken to use the Microlase only in the presence of a widely dilated pupil.

Mesh:

Year:  1991        PMID: 1854689      PMCID: PMC1042401          DOI: 10.1136/bjo.75.7.386

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  4 in total

1.  Variation of energy density in argon laser photocoagulation.

Authors:  O Pomerantzeff; C L Schepens
Journal:  Arch Ophthalmol       Date:  1975-10

2.  Wavelength selection in macular photocoagulation. Tissue optics, thermal effects, and laser systems.

Authors:  M A Mainster
Journal:  Ophthalmology       Date:  1986-07       Impact factor: 12.079

3.  Laser photodisruptors. Damage mechanisms, instrument design and safety.

Authors:  M A Mainster; D H Sliney; C D Belcher; S M Buzney
Journal:  Ophthalmology       Date:  1983-08       Impact factor: 12.079

4.  Initial clinical experience using a diode laser in the treatment of retinal vascular disease.

Authors:  J D McHugh; J Marshall; T J Ffytche; A M Hamilton; A Raven; C R Keeler
Journal:  Eye (Lond)       Date:  1989       Impact factor: 3.775

  4 in total
  1 in total

1.  Bilateral hyphaema following diode laser for retinopathy of prematurity.

Authors:  P Rundle; F G McGinnity
Journal:  Br J Ophthalmol       Date:  1995-11       Impact factor: 4.638

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.